EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H17F3N4O3 |
| Net Charge | 0 |
| Average Mass | 478.430 |
| Monoisotopic Mass | 478.12528 |
| SMILES | [H][C@@]12c3cc(Oc4ccnc5c4CCC(=O)N5)ccc3O[C@]1([H])[C@H]2c1nc2ccc(C(F)(F)F)cc2n1 |
| InChI | InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1 |
| InChIKey | NGFFVZQXSRKHBM-FKBYEOEOSA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lifirafenib (CHEBI:756640) has role antineoplastic agent (CHEBI:35610) |
| lifirafenib (CHEBI:756640) is a aromatic ether (CHEBI:35618) |
| INN | Source |
|---|---|
| lifirafenib | WHO MedNet |
| Synonyms | Source |
|---|---|
| Beigene-283 | ChEMBL |
| Bgb 283 | ChEMBL |
| BGB-283 | ChEMBL |
| Citations |
|---|